Thomas Wakim
Stock Analyst at Bell Potter
(0.11)
# 12,008
Out of 12,268 analysts
94
Total ratings
31%
Success rate
-17.8%
Average return
Main Sectors:
Stocks Rated by Thomas Wakim
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: ALC Alcidion Group Limited | Maintained: Buy | $0.16 | $0.112 | +42.86% | 13 | May 25, 2026 | |
| ASX: CUV Clinuvel Pharmaceuticals Limited | Maintained: Buy | $19 → $17 | $8.81 | +92.96% | 5 | May 24, 2026 | |
| ASX: CSL CSL Limited | Maintained: Hold | $155 → $100 | $97.17 | +2.91% | 9 | May 11, 2026 | |
| ASX: NEU Neuren Pharmaceuticals Limited | Maintained: Buy | $22 | $14.30 | +53.85% | 14 | May 8, 2026 | |
| ASX: SNT Syntara Limited | Maintained: Buy | $0.06 | $0.026 | +130.77% | 4 | May 4, 2026 | |
| ASX: MAP Microba Life Sciences Limited | Maintained: Buy | $0.13 → $0.12 | $0.072 | +66.67% | 12 | May 1, 2026 | |
| ASX: CGS Cogstate Limited | Maintained: Buy | $2.9 → $3.2 | $2.55 | +25.74% | 3 | Apr 9, 2026 | |
| ASX: GSS Genetic Signatures Limited | Downgraded: Hold | $0.55 → $0.1 | $0.076 | +31.58% | 8 | Apr 7, 2026 | |
| ASX: PYC PYC Therapeutics Limited | Maintained: Buy | $2.3 | $1.37 | +68.25% | 7 | Mar 17, 2026 | |
| ASX: IMM Immutep Limited | Downgraded: Hold | $0.65 → $0.07 | $0.056 | +25.00% | 8 | Mar 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.42 | $0.14 | +200.00% | 2 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $0.09 → $0.1 | $0.021 | n/a | 5 | May 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1.3 → $0.05 | $0.60 | n/a | 4 | Apr 1, 2025 |
Alcidion Group Limited
May 25, 2026
Maintained: Buy
Price Target: $0.16
Current: $0.112
Upside: +42.86%
Clinuvel Pharmaceuticals Limited
May 24, 2026
Maintained: Buy
Price Target: $19 → $17
Current: $8.81
Upside: +92.96%
CSL Limited
May 11, 2026
Maintained: Hold
Price Target: $155 → $100
Current: $97.17
Upside: +2.91%
Neuren Pharmaceuticals Limited
May 8, 2026
Maintained: Buy
Price Target: $22
Current: $14.30
Upside: +53.85%
Syntara Limited
May 4, 2026
Maintained: Buy
Price Target: $0.06
Current: $0.026
Upside: +130.77%
Microba Life Sciences Limited
May 1, 2026
Maintained: Buy
Price Target: $0.13 → $0.12
Current: $0.072
Upside: +66.67%
Cogstate Limited
Apr 9, 2026
Maintained: Buy
Price Target: $2.9 → $3.2
Current: $2.55
Upside: +25.74%
Genetic Signatures Limited
Apr 7, 2026
Downgraded: Hold
Price Target: $0.55 → $0.1
Current: $0.076
Upside: +31.58%
PYC Therapeutics Limited
Mar 17, 2026
Maintained: Buy
Price Target: $2.3
Current: $1.37
Upside: +68.25%
Immutep Limited
Mar 16, 2026
Downgraded: Hold
Price Target: $0.65 → $0.07
Current: $0.056
Upside: +25.00%
Aug 7, 2025
Maintained: Buy
Price Target: $0.42
Current: $0.14
Upside: +200.00%
May 13, 2025
Maintained: Hold
Price Target: $0.09 → $0.1
Current: $0.021
Upside: n/a
Apr 1, 2025
Downgraded: Sell
Price Target: $1.3 → $0.05
Current: $0.60
Upside: n/a